| Literature DB >> 32418592 |
Ken Fujioka1, Samantha R Harris2.
Abstract
There are many valid reasons why health care providers are reluctant to use pharmacotherapy for weight management: the negative track record of weight loss medications has led to numerous safety concerns, and there is lack of formal training in obesity medicine and a general discomfort with using these medications. New medications have improved safety profiles, and their mechanisms are based on recent discoveries of how humans regulate weight. This, combined with a change in American health coverage, has slowly increased the use weight loss medication. This article examines the barriers and changes that are increasing the use of anti-obesity medications.Entities:
Keywords: Barriers; Obesity; Pharmacotherapy; Reimbursement; Weight loss
Mesh:
Substances:
Year: 2020 PMID: 32418592 DOI: 10.1016/j.ecl.2020.02.007
Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN: 0889-8529 Impact factor: 4.741